London , EC1M 6BQ
United Kingdom
Queen Mary University of London - Barts Cancer Institute
COVID-19, SARS-CoV-2, hepatobiliary disease, pancreatic disease, hepato-pancreato-biliary cancer, hepato-pancreato-biliary disease, gender, ethnicity, diabetes, hypertension, high cholesterol, cardiovascular disease, respiratory disease, kidney disease, multi-morbidity, smoking, drinking, substance-misuse, obesity, regular medication use, post COVID-19 diagnosis complications
Colorectal cancer survivors, Comorbidity, Incidence, Primary care, Population-based cohort study, Long-term conditions
genomics, transcriptomics, translational, pancreas biobank, biomarkers